Canadian Pulmonary Fibrosis Foundation

Media Kit

Here are resources for members of the media. If you have any questions or wish to schedule an interview, please contact our media team.

Key Contacts

CPFF Board of Directors

Executive Director, Canadian Pulmonary Fibrosis Foundation

Board Chair, Canadian Pulmonary Fibrosis Foundation

Medical Professionals

Chair of CPFF Medical Advisory Council, Founding Chair of Canadian Thoracic Society’s Clinical Assembly on Interstitial Lung Diseases, Director of the University of Calgary Interstitial Lung Disease Program.

Division Head of Rheumatology at St. Joseph’s Health Centre in London, Ontario. Professor of Medicine in the Division of Rheumatology and also Epidemiology and Biostatistics at the University of Western Ontario, Schulich School of Medicine, London, Ontario.

Patients and Caregivers

Patient, Vancouver, BC, CPFF Board of Directors
Misdiagnosed and delay in diagnosis.

Patient, Winnipeg, MB
Lung transplant recipient.

Patient, Toronto, ON, CPFF Board of Directors
Lung transplant recipient.

Patient, Nova Scotia
Misdiagnosed, PF treatment was ineffective. Lung transplant recipient.

Woman standing in park looking at camera, wearing a blue PF tshirt. — Jackie Clarke

Carries the gene for PF, Calgary, AB
Pulmonary fibrosis runs in her family.

Patient, Ottawa, ON, CPFF Board of Directors
Living with pulmonary fibrosis.

Wendy Khan

PF Caregiver, Montreal, QC
Recently lost father to PF.

Press Release

Early Pulmonary Fibrosis detection holds the key to better health outcomes for Canadians living with COVID-19 and rheumatoid arthritis.

Canadians who have had COVID-19, and other chronic diseases, are experiencing Pulmonary Fibrosis (PF) at significantly higher rates than others, seemingly providing a causal link that researchers are investigating.

Etobicoke, Ontario (February 28, 2024). When is a cough, just a cough? And when is it more than that?

In recognition of Rare Disease Day, these are two simple questions the Canadian Pulmonary Fibrosis Foundation (CPFF) wants hundreds of thousands of Canadians who are dealing with long-term COVID-19 and other chronic illnesses to think about, because their life can truly depend on knowing the answer.

COVID-19 link with PF looms large for thousands of Canadians

Research is shedding light on the growing rate of pulmonary fibrosis (PF) being found in people suffering from long-term COVID-19.

Many with connective tissue diseases also more prone to PF

Researchers also show significant increases in PF for the hundreds of thousands of Canadians suffering from connective tissue diseases such as rheumatoid arthritis, myositis, lupus and scleroderma.

Read Rare Disease Campaign press release.